Compound Detail
CHEMBL3039502
DUVELISIB 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL3039502 |
| Name | DUVELISIB |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | SJVQHLPISAIATJ-ZDUSSCGKSA-N |
| Therapeutic | ✓ Yes |
21
Targets
62
Activities
2
Assay Types
7
PK Parameters
20
Publications
4
Known Names
20
Indications
Molecular Properties
416.9
MW (Da)
4.48
ALogP
6
HBA
2
HBD
88.5
PSA (Ų)
0.45
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2018 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Indications
Leukemia, Lymphocytic, Chronic, B-Cell Lymphoma, Follicular Neoplasms Neoplasms Arthritis, Rheumatoid Asthma Carcinoma, Squamous Cell Hematologic Neoplasms Leukemia Leukemia, Lymphoid Lymphoma Lymphoma, Non-Hodgkin Lymphoma, T-Cell, Peripheral Severe Acute Respiratory Syndrome Liver Diseases Melanoma Mycosis Fungoides Precursor Cell Lymphoblastic Leukemia-Lymphoma Sezary Syndrome Lymphoma, Large B-Cell, Diffuse
ATC Classification
L01EM04
duvelisib
Level 1: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Level 2: ANTINEOPLASTIC AGENTS
Activity Summary
IC50 58 meas. best 9.62
EC50 4 meas. best 8.3
Target Activity Profile
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 844.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 2134.0 | ng.hr.mL-1 | Mus musculus |
| Cmax | 1784.73 | nM | Mus musculus |
| Cmax | 7189.29 | nM | Mus musculus |
| F | 82.3 | % | Mus musculus |
| T1/2 | 0.14 | hr | Mus musculus |
| T1/2 | 1.18 | hr | Mus musculus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 39163191 | 10.1021/acs.jmedchem.4c00817 | ADMET | 8 |
| 27774127 | 10.1021/acsmedchemlett.6b00209 | NON-PROTEIN TARGET | 6 |
| 37468498 | 10.1038/s41467-023-40064-9 | D(1A) dopamine receptor | 4 |
| 30582813 | 10.1021/acs.jmedchem.8b01298 | Unchecked | 4 |
| 35831917 | 10.1021/acs.jmedchem.2c00568 | Unchecked | 4 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-1A adrenergic receptor | 3 |
| 31033293 | 10.1021/acs.jmedchem.8b02014 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Prostaglandin G/H synthase 1 | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2B | 3 |
| 31033293 | 10.1021/acs.jmedchem.8b02014 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 1A | 3 |
| 35831917 | 10.1021/acs.jmedchem.2c00568 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-2A adrenergic receptor | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Progesterone receptor | 3 |
| 35831917 | 10.1021/acs.jmedchem.2c00568 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M2 | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Estrogen receptor | 3 |
| 27774127 | 10.1021/acsmedchemlett.6b00209 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Glucocorticoid receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Peroxisome proliferator-activated receptor gamma | 2 |
Data from ChEMBL 36 via Core Engine